Cited by 3,605Angiogenesis and VEGF in CancerLymphatic System and DiseasesCancer, Hypoxia, and Metabolism

The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

Kim, K. Jin, Li, Bing, Winer, Jane, Armanini, Mark, Gillett, Nancy, Phillips, Heidi S., Ferrara, Napoleone·1993·Nature

Open this paper in CoChat — free account

Abstract

The development of new blood vessels (angiogenesis) is required for many physiological processes including embryogenesis, wound healing and corpus luteum formation. Blood vessel neoformation is also important in the pathogenesis of many disorders, particularly rapid growth and metastasis of solid tumours. There are several potential mediators of tumour angiogenesis, including basic and acidic fibroblast growth factors, tumour necrosis factor-alpha and transforming factors-alpha and -beta. But it is unclear whether any of these agents actually mediates angiogenesis and tumour growth in vivo. Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen and an angiogenesis inducer released by a variety of tumour cells and expressed in human tumours in situ. To test whether VEGF may be a tumour angiogenesis factor in vivo, we injected human rhabdomyosarcoma, glioblastoma multiforme or leiomyosarcoma cell lines into nude mice. We report here that treatment with a monoclonal antibody specific for VEGF inhibited the growth of the tumours, but had no effect on the growth rate of the tumour cells in vitro. The density of vessels was decreased in the antibody-treated tumours. These findings demonstrate that inhibition of the action of an angiogenic factor spontaneously produced by tumour cells may suppress tumour growth in vivo.

Integrity signals

Registry

Crossref · 10.1038/362841a0

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,598
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 5,000
Self-citation
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,509
Angiogenesis.
Folkman, J., & Shing, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49853-0 · Cited by 2,651
Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,269
Self-citation
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
Plate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,262
Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGF
Keck, P. J., Hauser, S. D., Krivi, G. G., Sanzo, K., Warren, T. G., Feder, J., & Connolly, D. T. (1989) · Science · doi:10.1126/science.2479987 · Cited by 2,058
The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing
Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., & Abraham, J. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99049-6 · Cited by 1,988
Molecular and Biological Properties of the Vascular Endothelial Growth Factor Family of Proteins
Ferrara, N., Houck, K. A., Jakeman, L. B., & LEUNG, D. W. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-18 · Cited by 1,655
Self-citation

Flagged first, then by citations

Show all 32 references

1 of the 32 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

Senger, D., Perruzzi, C. A., Feder, J. & Dvorak, H. F. Cancer Res. 46, 5629 (1986).
Westphal, M. et al. Expl cell. Biol. 55, 152–161 (1987).

Sorted by citations

Items 901–1,000 of 1,006

Evaluation of the Prognostic Role of Vascular Endothelial Growth Factor and Microvessel Density in Stages I and II Breast Cancer Patients
Ludovini, V., Sidoni, A., Pistola, L., Bellezza, G., Angelis, V. D., Gori, S., Mosconi, A. M., Bisagni, G., Cherubini, R., Bian, A. R., et al. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1025755717912 · Cited by 99
Rationale for Combination Therapies for Choroidal Neovascularization
Spaide, R. F. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.07.025 · Cited by 99
A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: Is the current literature meaningful?
Hormbrey, E., Gillespie, P., TURNER, K. J., Han, C., Roberts, A. H. N., McGrouther, D. A., & Harris, A. L. (2002) · Clinical & Experimental Metastasis · doi:10.1023/a:1021379811308 · Cited by 99
Association of vascular endothelial growth factor expression with tumor angiogenesis, survival and thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in human colorectal cancer
Amaya, H., Tanigawa, N., Lu, C., Matsumura, M., Shimomatsuya, T., Horiuchi, T., & Muraoka, R. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)00280-2 · Cited by 99
Polymeric Nanoparticles in Brain Cancer Therapy: A Review of Current Approaches
Caraway, C. A., Gaitsch, H., Wicks, E. E., Kalluri, A. L., Kunadi, N., & Tyler, B. (2022) · Polymers · doi:10.3390/polym14142963 · Cited by 102
Quantitative analysis of microvascular changes in diffuse astrocytic neoplasms with increasing grade of malignancy
Wesseling, P., van der Laak, J. A. W. M., Link, M., Teepen, H. L. J. M., & Ruiter, D. J. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90115-0 · Cited by 98
Target molecules for anti-angiogenic therapy: from basic research to clinical trials
Hagedorn, M., & Bikfalvi, A. (2000) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00056-1 · Cited by 102
Pituitary adenylate cyclase-activating polypeptide, interleukin-6 and glucocorticoids regulate the release of vascular endothelial growth factor in pituitary folliculostellate cells
Gloddek, J., Pagotto, U., Páez-Pereda, M., ARZT, E. S., Stalla, G. K., & Renner, U. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1600483 · Cited by 98
Insulin-like growth factor-binding protein-6 and cancer
Bach, L. A., Fu, P., & Yang, Z. (2012) · Clinical Science · doi:10.1042/cs20120343 · Cited by 97
VEGF in Tumor Progression and Targeted Therapy
Chekhonin, V. P., Shein, S. A., Korchagina, A. A., & Gurina, O. I. (2013) · Current Cancer Drug Targets · doi:10.2174/15680096113139990074 · Cited by 99
Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density.
Hague, S. J., Zhang, L., Oehler, M. K., Manek, S., MacKenzie, I. Z., Bicknell, R., & REES, M. C. P. (2000) · PubMed · Cited by 97
The biology of vascular endothelial growth factor-B (VEGF-B)
Nash, A. D., Baca, M., Wright, C. E., & Scotney, P. D. (2005) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2005.02.007 · Cited by 103
Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584
THOMAS, A., Morgan, B., Drevs, J., Unger, C., Wiedenmann, B. J., Vanhoefer, U. J., Laurent, D., Dugan, M. H., & Steward, W. P. (2003) · Seminars in Oncology · doi:10.1016/s0093-7754(03)70023-2 · Cited by 97
Angiogenesis in cancer - general pathways and their therapeutic implications
Dimova, I. I., Popivanov, G., & Djonov, V. (2014) · PubMed · doi:10.7892/boris.83821 · Cited by 96
Impact of Exploratory Biomarkers on the Treatment Effect of Bevacizumab in Metastatic Breast Cancer
Jubb, A. M., Miller, K. D., Rugo, H. S., Harris, A. L., Chen, D., Reimann, J. D., Cobleigh, M., Schmidt, M., Langmuir, V. K., Hillan, K. J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1791 · Cited by 101
Targeting 4-1BB Costimulation to the Tumor Stroma with Bispecific Aptamer Conjugates Enhances the Therapeutic Index of Tumor Immunotherapy
Schrand, B., Berezhnoy, A., Brenneman, R., Williams, A. J., Levay, A. K., Kong, L.-Y., Rao, G., Zhou, S., Heimberger, A. B., & Gilboa, E. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0007 · Cited by 97
Role of targeted therapy in metastatic colorectal cancer
Ohhara, Y., Fukuda, N., Takeuchi, S., Honma, R., Shimizu, Y., Kinoshita, I., & Dosaka‐Akita, H. (2016) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v8.i9.642 · Cited by 99
Bevacizumab and weekly taxane chemotherapy demonstrates activity in refractory ovarian cancer
Cohn, D. E., Valmadre, S., Resnick, K. E., Eaton, L. A., Copeland, L. J., & Fowler, J. M. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.01.030 · Cited by 96
Integrin receptors: the dynamic modulators of endometrial function
Reddy, K. V. R., & Mangale, S. S. (2003) · Tissue and Cell · doi:10.1016/s0040-8166(03)00039-9 · Cited by 96
Resistance to epidermal growth factor receptor-targeted therapy
Morgillo, F., & Lee, H. (2005) · Drug Resistance Updates · doi:10.1016/j.drup.2005.08.004 · Cited by 96
Bevacizumab Suppression of Establishment of Micrometastases in Experimental Ocular Melanoma
Yang, H., Jager, M. J., & Grossniklaus, H. E. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4755 · Cited by 96
Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas
Jansen, M., Hamer, P. C. D. W., Witmer, A. N., Troost, D., & Noorden, C. J. F. V. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.03.001 · Cited by 96
Molecular foundations of cancer: New targets for intervention
Karp, J. E., & Broder, S. E. (1995) · Nature Medicine · doi:10.1038/nm0495-309 · Cited by 96
Inhibition of angiogenesis-driven Kaposi's sarcoma tumor growth in nude mice by oral N-acetylcysteine.
Albini, A., Morini, M., D’Agostini, F., Ferrari, N., Campelli, F., Arena, G., Noonan, D. M., Pesce, C. M., & Flora, S. D. (2001) · PubMed · Cited by 97
Antiangiogenic chemotherapeutic agents: characterization in comparison to their tumor growth inhibition in human renal cell carcinoma models.
Schirner, M., Hoffmann, J., Menrad, A., & Schneider, M. R. (1998) · PubMed · Cited by 95
Efficient siRNA delivery using water soluble lipopolymer for anti-angiogenic gene therapy
Kim, W. J., Chang, C., Lee, M., & Kim, S. W. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.12.026 · Cited by 95
Expression of vascular endothelial growth factor in human brain tumors
Nishikawa, R., Cheng, S., Nagashima, R., Huang, H., Cavenee, W. K., & Matsutani, M. (1998) · Acta Neuropathologica · doi:10.1007/s004010050919 · Cited by 95
Aptamers as functional nucleic acids:In vitro selection and biotechnological applications
You, K. M., Lee, S. H., Im, A., & Lee, S. B. (2003) · Biotechnology and Bioprocess Engineering · doi:10.1007/bf02940259 · Cited by 95
Pro-angiogenic cytokines and their role in tumor angiogenesis
Neufeld, G., & Kessler, O. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9011-5 · Cited by 95
Targeted Therapy of Colorectal Cancer: Clinical Experience with Bevacizumab
Fernando, N. H., & Hurwitz, H. I. (2004) · The Oncologist · doi:10.1634/theoncologist.9-suppl_1-11 · Cited by 95
Natriuretic Peptides Suppress Vascular Endothelial Cell Growth Factor Signaling to Angiogenesis
Pedram, A., Razandi, M., & Levin, E. R. (2001) · Endocrinology · doi:10.1210/endo.142.4.8099 · Cited by 95
Inflammation as a Target for Prostate Cancer Chemoprevention: Pathological and Laboratory Rationale
Lucia, M. S., & Torkko, K. C. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000108142.53241.47 · Cited by 95
Bevacizumab—current status and future directions
Midgley, R. S., & Kerr, R. S. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi208 · Cited by 95
Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 antisense oligonucleotides.
Chen, Z.-Q., Fisher, R. J., Riggs, C. W., Rhim, J. S., & Lautenberger, J. A. (1997) · PubMed · Cited by 95
MicroRNA-205 functions as a tumor suppressor in human glioblastoma cells by targeting VEGF-A
Yue, X., Wang, P., Xu, J., Zhu, Y., Sun, G., Pang, Q., & Tao, R. (2011) · Oncology Reports · doi:10.3892/or.2011.1588 · Cited by 94
Metformin combined with quercetin synergistically repressed prostate cancer cells via inhibition of VEGF/PI3K/Akt signaling pathway
Sun, S., Gong, F., Liu, P., & Miao, Q. (2018) · Gene · doi:10.1016/j.gene.2018.04.045 · Cited by 94
The Voltage-dependent Anion Channel Is a Receptor for Plasminogen Kringle 5 on Human Endothelial Cells
Gonzalez–Gronow, M., Kalfa, T. A., Johnson, C. E., Gawdi, G., & Pizzo, S. V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303172200 · Cited by 94
Molecular regulation of tumor angiogenesis: mechanisms and therapeutic implications
Harper, J. W., & Moses, M. A. (2006) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7378-4_10 · Cited by 95
Wogonin suppresses tumor growth in vivo and VEGF-induced angiogenesis through inhibiting tyrosine phosphorylation of VEGFR2
Lu, N., Gao, Y., Ling, Y., Chen, Y., Yang, Y., Gu, H.-Y., Qi, Q., Liu, W., Wang, X., You, Q., et al. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.02.013 · Cited by 94
Circulating Vascular Endothelial Growth Factor in Patients With Colorectal Cancer
Fujisaki, K., Mitsuyama, K., Toyonaga, A., Matsuo, K., & Tanikawa, K. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(97)00054-3 · Cited by 94
Tumour vasculature - a potential therapeutic target
Baillie, C., Winslet, M. C., & Bradley, N. J. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.323 · Cited by 95
Gambogic acid inhibits angiogenesis through suppressing vascular endothelial growth factor-induced tyrosine phosphorylation of KDR/Flk-1
Lu, N., Yang, Y., You, Q., Ling, Y., Gao, Y., Gu, H.-Y., Zhao, L., Wang, X., & Guo, Q. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.08.015 · Cited by 93
Resistance to Anti-angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the Drugs
Montemagno, C., & Pagès, G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00584 · Cited by 100
Nucleic acid aptamers for target validation and therapeutic applications.
Pendergrast, P. S., Marsh, H. N., Grate, D., Healy, J. M., & Stanton, M. J. (2005) · PubMed Central · Cited by 93
Placental vascular morphogenesis
Jones, D. S., & Burton, G. J. (2000) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1053/beog.2000.0137 · Cited by 96
Targeting Angiogenesis in Squamous Non-Small Cell Lung Cancer
Piperdi, B., Merla, A., & Perez-Soler, R. (2014) · Drugs · doi:10.1007/s40265-014-0182-z · Cited by 93
Profilin-1 phosphorylation directs angiocrine expression and glioblastoma progression through HIF-1α accumulation
Fan, Y., Potdar, A. A., Gong, Y., Eswarappa, S. M., Donnola, S. B., Lathia, J. D., Hambardzumyan, D., Rich, J. N., & Fox, P. L. (2014) · Nature Cell Biology · doi:10.1038/ncb2954 · Cited by 95
Pancreatic cancer cell-derived vascular endothelial growth factor is biologically activein vitro and enhances tumorigenicityin vivo
Luo, J., Guo, P., Matsuda, K., Truong, N., Lee, A., Chun, C. L., Cheng, S., & Korc, M. (2001) · International Journal of Cancer · doi:10.1002/ijc.1202 · Cited by 93
The airway vasculature: recent advances and clinical implications
Paredi, P., & Barnes, P. J. (2009) · Thorax · doi:10.1136/thx.2008.100032 · Cited by 93
A role for hypoxia and hypoxia-inducible transcription factors in tumor physiology
Acker, T., & Plate, K. H. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0355-1 · Cited by 94
MDM2 Regulates Vascular Endothelial Growth Factor mRNA Stabilization in Hypoxia
Zhou, S., Gu, L., He, J., Zhang, H., & Zhou, M. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.06085-11 · Cited by 99
Inhibition of Tumor Growth and Metastasis by Targeting Tumor-Associated Angiogenesis with Antagonists to the Receptors of Vascular Endothelial Growth Factor
Zhu, Z., & Witte, L. (1999) · Investigational New Drugs · doi:10.1023/a:1006314501634 · Cited by 93
p53 expression and risk factors for cutaneous melanoma: A case-control study
Whiteman, D. C., Parsons, P. G., & Green, A. C. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980911)77:6 · Cited by 154
Rat brain VEGF expression in alveolar hypoxia: possible role in high-altitude cerebral edema
Xu, F., & Severinghaus, J. W. (1998) · Journal of Applied Physiology · doi:10.1152/jappl.1998.85.1.53 · Cited by 93
Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice.
Pötgens, A. J. G., Lubsen, N. H., van Altena, M. C., Schoenmakers, J. G. G., Ruiter, D. J., & de Waal, R. M. W. (1995) · Europe PMC (PubMed Central) · Cited by 93
Angiogenic growth factors in neural embryogenesis and neoplasia.
Zagzag, D. (1995) · Europe PMC (PubMed Central) · Cited by 92
Cytotoxic and antitumor effects of brucine on Ehrlich ascites tumor and human cancer cell line
Agrawal, S. S., Saraswati, S., Mathur, R., & Pandey, M. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.05.020 · Cited by 92
Current treatment of optic nerve gliomas
Farazdaghi, M. K., Katowitz, W. R., & Avery, R. A. (2019) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000587 · Cited by 92
The discovery of angiogenic factors:
Ribatti, D., Vacca, A., & Presta, M. (2000) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(01)00112-4 · Cited by 92
Clinical significance of vascular endothelial growth factor and hepatocyte growth factor in multiple myeloma
Iwasaki, T., Hamano, T., Ogata, A., Hashimoto, N., Kitano, M., & Kakishita, E. (2002) · British Journal of Haematology · doi:10.1046/j.0007-1048.2002.03364.x · Cited by 91
Involvement of CTGF, a Hypertrophic Chondrocyte-Specific Gene Product, in Tumor Angiogenesis
Shimo, T., Nakanishi, T., Nishida, T., Asano, M., Sasaki, A., Kanyama, M., Kuboki, T., Matsumura, T., & Takigawa, M. (2001) · Oncology · doi:10.1159/000055339 · Cited by 92
Tumour‐associated angiogenesis in human colorectal cancer
Rmali, K. A., Puntis, M. C. A., & Jiang, W. G. (2006) · Colorectal Disease · doi:10.1111/j.1463-1318.2006.01089.x · Cited by 93
Therapeutic Anti-VEGF Antibodies
Lien, S., & Lowman, H. B. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-73259-4_6 · Cited by 94
Current Status Of Antiangiogenic Factors
Talks, K., & Harris, A. L. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01864.x · Cited by 91
KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells
Yoshiji, H., Kuriyama, S., Hicklin, D. J., Huber, J., Yoshii, J., Miyamoto, Y., Kawata, M., Ikenaka, Y., Nakatani, T., Tsujinoue, H., et al. (1999) · Hepatology · doi:10.1002/hep.510300509 · Cited by 94
Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration.
Xiong, S., Grijalva, R., Zhang, L., Nguyen, N. T., Pisters, P. W. T., Pollock, R. E., & Yu, D. (2001) · PubMed · Cited by 92
Troglitazone Treatment Increases Plasma Vascular Endothelial Growth Factor in Diabetic Patients and Its mRNA in 3T3-L1 Adipocytes
Emoto, M., Anno, T., Satō, Y., Tanabe, K., Okuya, S., Tanizawa, Y., Matsutani, A., & Oka, Y. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1166 · Cited by 92
A meta-analysis of randomized controlled trials comparing chemotherapy plus bevacizumab with chemotherapy alone in metastatic colorectal cancer
Cao, Y., Tan, A., Gao, F., Liu, L., Liao, C., & Mo, Z. (2009) · International Journal of Colorectal Disease · doi:10.1007/s00384-009-0655-9 · Cited by 90
Biomarkers in Tumor Angiogenesis and Anti-Angiogenic Therapy
Pircher, A., Hilbe, W., Heidegger, I. M., Drevs, J., Tichelli, A., & Medinger, M. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12107077 · Cited by 92
Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms
Miletić, H., Niclou, S. P., Johansson, M., & Bjerkvig, R. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220902806444 · Cited by 95
Melanoma-associated expression of vascular endothelial growth factor and its receptors FLT-1 and KDR
Graeven, U., Fiedler, W., Karpinski, S., Ergün, S., Kilic, N., Rodeck, U., Schmiegel, W., & HOSSFELD, D. K. (1999) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050325 · Cited by 91
Role of Vascular Endothelial Growth Factor–A in Recurrent Respiratory Papillomatosis
Vargas, S. O., Healy, G. B., Rahbar, R., Folkman, J., Tan, X., McGill, T. J., & Brown, L. F. (2005) · Annals of Otology Rhinology & Laryngology · doi:10.1177/000348940511400407 · Cited by 91
Novel antibodies as anticancer agents
Zafir‐Lavie, I., Michaeli, Y., & Reiter, Y. (2007) · Oncogene · doi:10.1038/sj.onc.1210372 · Cited by 100
Molecular Biology for the Radiation Oncologist: the 5Rs of Radiobiology meet the Hallmarks of Cancer
Harrington, K. J., Jankowska, P., & Hingorani, M. (2007) · Clinical Oncology · doi:10.1016/j.clon.2007.04.009 · Cited by 91
The neurotrophin-trk receptor axes are critical for the growth and progression of human prostatic carcinoma and pancreatic ductal adenocarcinoma xenografts in nude mice.
Miknyoczki, S. J., Wan, W., Chang, H., Dobrzański, P., Ruggeri, B., Dionne, C. A., & Buchkovich, K. J. (2002) · PubMed · Cited by 91
LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis
Piccolo, E., Tinari, N., Semeraro, D., Traini, S., Fichera, I., Cumashi, A., Sorda, R. L., Spinella, F., Bagnato, A., Lattanzio, R., et al. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0936-6 · Cited by 91
Therapies directed at vascular endothelial growth factor
Manley, P. W., Martiny‐Baron, G., Schlaeppi, J.-M., & Wood, J. M. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.12.1715 · Cited by 91
The Regulation of Blood Vessel Growth by Vascular Endothelial Growth Factor
Ferrara, N., Heinsohn, H. G., Walder, C. E., Bunting, S., & THOMAS, G. R. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb17435.x · Cited by 91
Self-citation
Role of vascular permeability factor/vascular endothelial growth factor in eye disease
Schlingemann, R. O., & van Hinsbergh, V. W. M. (1997) · British Journal of Ophthalmology · doi:10.1136/bjo.81.6.501 · Cited by 91
Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis
Raimondo, F. D., Azzaro, M. P., Palumbo, G. A., Bagnato, S., Stagno, F., Giustolisi, G., Cacciola, E., Sortino, G., Guglielmo, P., & Giustolisi, R. (2001) · Leukemia · doi:10.1038/sj.leu.2402124 · Cited by 91
Radiation-Enhanced Vascular Endothelial Growth Factor (VEGF) Secretion in Glioblastoma Multiforme Cell Lines – A Clue to Radioresistance?
Hovinga, K. E., Stalpers, L. J. A., van Bree, C., Donker, M., Verhoeff, J. J. C., Rodermond, H. M., Bosch, D. A., & van Furth, W. R. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-4204-7 · Cited by 90
Tenascin‐C regulates angiogenesis in tumor through the regulation of vascular endothelial growth factor expression
Tanaka, K., Hiraiwa, N., Hashimoto, H., Yamazaki, Y., & Kusakabe, M. (2003) · International Journal of Cancer · doi:10.1002/ijc.11509 · Cited by 90
Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid
Gee, M. F. W., Tsuchida, R., Eichler-Jonsson, C., Das, B., Baruchel, S., & Malkin, D. M. (2005) · Oncogene · doi:10.1038/sj.onc.1208939 · Cited by 90
Dimethylarginine dimethylaminohydrolase I enhances tumour growth and angiogenesis
Kostourou, V., Robinson, S. P., Cartwright, J. E., & Whitley, G. S. J. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600518 · Cited by 90
Identification of Macrophage Migration Inhibitory Factor as a Potent Endothelial Cell Growth-Promoting Agent Released by Ectopic Human Endometrial Cells
Yang, Y., Degranpré, P., Kharfi, A., & Akoum, A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7003 · Cited by 92
Chemotherapy with Targeted Agents for the Treatment of Metastatic Colorectal Cancer
Köhne, C., & Lenz, H. (2009) · The Oncologist · doi:10.1634/theoncologist.2008-0202 · Cited by 91
Angiogenic inhibition mediated by a DNAzyme that targets vascular endothelial growth factor receptor 2.
Zhang, L., Gasper, W. J., Stass, S. A., Ioffe, O. B., Davis, M. A., & Mixson, A. J. (2002) · PubMed · Cited by 90
Combined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosis.
Zhang, L., Yu, D., Hicklin, D. J., Hannay, J. A. F., Ellis, L. M., & Pollock, R. E. (2002) · PubMed · Cited by 90
Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition
Yoo, J. Y., Kim, J.-H., Kim, J., Huang, J.-H., Zhang, S.-N., Kang, Y.-A., Kim, H., & Yun, C.-O. (2008) · Gene Therapy · doi:10.1038/gt.2008.3 · Cited by 90
Dynamic regulation of VEGF-inducible genes by an ERK-ERG-p300 transcriptional network
Fish, J. E., Gutierrez, M. E. C., Dang, L. T. H., Khyzha, N., Chen, Z., Veitch, S., Cheng, H. S., Khor, M., Antounians, L., Njock, M., et al. (2017) · Development · doi:10.1242/dev.146050 · Cited by 88
Current targeted therapies in the treatment of advanced colorectal cancer: a review
Moriarity, A., O’Sullivan, J., Kennedy, J., Mehigan, B., & McCormick, P. (2016) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834016646734 · Cited by 87
Potent neutralization of VEGF biological activities with a fully human antibody Fab fragment directed against VEGF receptor 2
Miao, H., Hu, K., Jimenez, X., Navarro, E. C., Zhang, H., Lu, D., Ludwig, D. L., Balderes, P. J., & Zhu, Z. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.119 · Cited by 89
Identification and characterization of a new splicing variant of vascular endothelial growth factor: VEGF183
Lei, J., Jiang, A., & Pei, D. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00240-1 · Cited by 89
A review of the latest clinical compounds to inhibit VEGF in pathological angiogenesis
Baka, S., Clamp, A. R., & Jayson, G. C. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.6.867 · Cited by 89
Incipient Angiogenesis
Folkman, J. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.2.94 · Cited by 90
Enhanced expression of Tie2, its ligand angiopoietin-1, vascular endothelial growth factor, and CD31 in human non-small cell lung carcinomas.
Takahama, M., Tsutsumi, M., Tsujiuchi, T., Nezu, K., Kushibe, K., Taniguchi, S., Kotake, Y., & Konishi, Y. (1999) · PubMed · Cited by 89
Vascular endothelial growth factor (VEGF) mRNA expression in human tumor models of different histologies
Berger, D. P., Herbstritt, L., Dengler, W. A., Marmé, D., Mertelsmann, R., & Fiebig, H. (1995) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a059322 · Cited by 89
Clinical Significance of Angiogenesis in Gastrointestinal Cancers
Poon, R. T. P., Fan, S.-T., & Wong, J. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000075047.47175.35 · Cited by 88
Antifibrotic activity of bevacizumab on human Tenon's fibroblasts in vitro
O'Neill, E. C., Qin, Q., Van Bergen, N. J., Connell, P. P., Vasudevan, S., Coote, M. A., Trounce, I. A., Wong, T. T. L., & Crowston, J. G. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-5669 · Cited by 73
The effect of environmental cues on the differentiation of myofibroblasts in peritoneal granulation tissue
(2000) · doi:10.1002/1096-9896(2000)9999:9999 · Cited by 70

Authors: Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N.
Affiliations: Genentech (US)
ORCID: Li, Bing
Armanini, Mark
Phillips, Heidi S.
Ferrara, Napoleone
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 1993-04
Volume: 362
Issue: 6423
Pages: 841-844
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/362841a0
OpenAlex: W1969328947
Cited by: 3,605
References: 32
Citations by year: 2026: 22 · 2025: 25 · 2024: 43 · 2023: 47 · 2022: 53 · 2021: 55 · 2020: 55 · 2019: 54 · 2018: 89 · 2017: 101 · 2016: 81 · 2015: 78 · 2014: 98 · 2013: 110 · 2012: 137
FWCI: 32.75
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords: vascular endothelial growth factor, angiogenesis, tumor angiogenesis, tumor growth inhibition, monoclonal antibodies, rhabdomyosarcoma, glioblastoma, leiomyosarcoma, tumor vasculature, nude mice, tumour metastasis
MeSH terms: Animals, Antibodies, Monoclonal, Cell Division, Female, Glioblastoma, Humans, Leiomyosarcoma, Lymphokines, Mice, Nude, Neoplasm Transplantation, Neoplasms, Experimental, Neovascularization, Pathologic, Rhabdomyosarcoma, Tumor Cells, Cultured, Endothelial Growth Factors, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks